MXPA03001952A - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones. - Google Patents

Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones.

Info

Publication number
MXPA03001952A
MXPA03001952A MXPA03001952A MXPA03001952A MXPA03001952A MX PA03001952 A MXPA03001952 A MX PA03001952A MX PA03001952 A MXPA03001952 A MX PA03001952A MX PA03001952 A MXPA03001952 A MX PA03001952A MX PA03001952 A MXPA03001952 A MX PA03001952A
Authority
MX
Mexico
Prior art keywords
compositions
making
methods
pharmaceutical compositions
flavoring systems
Prior art date
Application number
MXPA03001952A
Other languages
English (en)
Spanish (es)
Inventor
Donald P Gauwitz
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA03001952A publication Critical patent/MXPA03001952A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
MXPA03001952A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones. MXPA03001952A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05
PCT/US2001/027415 WO2002020057A2 (en) 2000-09-05 2001-09-04 Flavoring systems for pharmaceutical compositions and methods of making such compositions

Publications (1)

Publication Number Publication Date
MXPA03001952A true MXPA03001952A (es) 2003-09-10

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001952A MXPA03001952A (es) 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones.

Country Status (10)

Country Link
EP (1) EP1315487A2 (ja)
JP (1) JP2004522698A (ja)
AR (1) AR030715A1 (ja)
AU (1) AU2001288695A1 (ja)
BR (1) BR0108433A (ja)
CA (1) CA2417258A1 (ja)
MX (1) MXPA03001952A (ja)
PE (1) PE20020373A1 (ja)
UY (1) UY26925A1 (ja)
WO (1) WO2002020057A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
MXPA05005335A (es) * 2002-11-22 2005-07-25 Firmenich & Cie Composiciones orales las cuales enmascaran el sabor salado de las sales.
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) * 1996-06-03 1998-01-05 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
EP1315487A2 (en) 2003-06-04
BR0108433A (pt) 2006-06-06
AU2001288695A1 (en) 2002-03-22
PE20020373A1 (es) 2002-05-13
CA2417258A1 (en) 2002-03-14
WO2002020057A3 (en) 2002-05-10
JP2004522698A (ja) 2004-07-29
WO2002020057A2 (en) 2002-03-14
UY26925A1 (es) 2002-04-26
AR030715A1 (es) 2003-09-03

Similar Documents

Publication Publication Date Title
HUP0303108A3 (en) Substituted pyrazoles and pharmaceutical compositions containing them
ZA200003997B (en) Pharmaceutical compositions.
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
AP2004003024A0 (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
ZA200207290B (en) Pharmaceutical compositions of glycogen phosphorylase inhibitors.
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
HUP0303998A3 (en) Phthalazinones derivatives and pharmaceutical compositions containing them
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
ZA200302014B (en) Methods and compositions for promoting the maturation of monocytes.
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
MXPA03000624A (es) Composiciones y peliculas para la elaboracion de capsulas.
MXPA03002105A (es) Composiciones farmaceuticas.
HUP0303074A3 (en) Benzodiazepine derivatives and pharmaceutical compositions them
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
MXPA03001952A (es) Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones.
HK1056564A1 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof.
HK1052168A1 (en) N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them.
AU2001272695A1 (en) Azithromocin monohydrate with lower hygroscopicity, preparation method and pharmaceutical compositions which include it
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof